Cargando…
Recent developments of imidazo[1,2-a]pyridine analogues as antituberculosis agents
Over the past 2000 years, tuberculosis (TB) has killed more people than any other infectious disease. In 2021, TB claimed 1.6 million lives worldwide, making it the second leading cause of death from an infectious disease after COVID-19. Unfortunately, TB drug discovery research was neglected in the...
Autores principales: | Samanta, Sauvik, Kumar, Sumit, Aratikatla, Eswar K., Ghorpade, Sandeep R., Singh, Vinayak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
RSC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131611/ https://www.ncbi.nlm.nih.gov/pubmed/37122538 http://dx.doi.org/10.1039/d3md00019b |
Ejemplares similares
-
Synthesis, study of antileishmanial and antitrypanosomal activity of imidazo pyridine fused triazole analogues
por: Nandikolla, Adinarayana, et al.
Publicado: (2020) -
Crystal Correlation Of Heterocyclic Imidazo[1,2-a]pyridine Analogues and Their Anticholinesterase Potential Evaluation
por: Kwong, Huey Chong, et al.
Publicado: (2019) -
Facile synthesis of 3-substituted imidazo[1,2-a]pyridines through formimidamide chemistry
por: Sivappa, Rasapalli, et al.
Publicado: (2019) -
Copper-catalyzed three-component reaction to synthesize polysubstituted imidazo[1,2-a]pyridines
por: Zhou, Zitong, et al.
Publicado: (2022) -
Collaborative virtual screening to elaborate an imidazo[1,2-a]pyridine hit series for visceral leishmaniasis
por: Akao, Yuichiro, et al.
Publicado: (2021)